Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / A••• P••••••• M••••••••• C••••••• L•••

A••• P••••••• M••••••••• C••••••• L•••

Institutional venture firmJackson, WYa•••••••••.comSEC venture capital fund adviserone firm, 6 filing advisers

This firm files as 6 advisers on a•••••••••.com: A••• P••••••• I•• I•••, A••• P••••••• I••• I•••, A••• P••••••• I••••••••• M••••••• L•••, A••• P••••••• I•• I•••, A••• P••••••• M••••••••• C••••. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

A••• P••••••• is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996.

venture manager, reported GAV $813M across 4 vehicles

Importance
28
moderate
Active deployment
4
low
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
5
low
Identity and regulatory footprint
Headquarters
Jackson, WYadviserinfo.sec.gov
Office address
115 W. SNOW KING AVE, SUITE 101B, Jackson, WY, 83001adviserinfo.sec.gov
Business phone
415-362-4022adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 16, 2026
Private funds reported
4 (4 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$588Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business phone
415-362-4022adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
Sectors
ai
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 1
Funds and vehicles
4 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
A••• P••••••• N•••••• F••• I••• L•••Fund2021 adv first reportedMature$118M
Mar 21, 2024
75$0
of $250M
Feb 17, 2021
A••••• H•••••••• L•••Fund2021 form d first saleMature$23.5M
Mar 21, 2024
8$20.0M
of $20.0M
Mar 24, 2021
A••• P••••••• N•••••• F••• I•• L•••Fund2019 adv first reportedMature$287M
Mar 21, 2024
40$0
of $150M
Feb 27, 2019
A••• P••••••• I•• L•••FundunknownUnknown$384M
Mar 21, 2024
25$0
of $200M
Feb 24, 2017
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
7 current, 0 departed
Investments on record
1 edges, 1 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
A••• P••••••• N•••••• F•••• L• P•••••portfolio listingunknownunknownunknownunknownSep 13, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
  1. Mar 25, 2021
    A••••• H•••••••• L••• first reported on Form ADV by A••• P••••••• M••••••••• C••••••• L••• (Venture Capital Fund), GAV $20,000,000
  2. Mar 25, 2021
    A••• P••••••• N•••••• F••• I••• L••• first reported on Form ADV by A••• P••••••• M••••••••• C••••••• L••• (Venture Capital Fund), GAV $275,000,000
  3. Mar 22, 2019
    A••• P••••••• N•••••• F••• I•• L••• first reported on Form ADV by A••• P••••••• M••••••••• C••••••• L••• (Venture Capital Fund)
  4. Apr 25, 2017
    A••• P••••••• M••••••••• C••••••• L••• first filed Form ADV (ERA, venture capital fund adviser exemption)
  5. Apr 25, 2017
    A••• P••••••• I•• L••• first reported on Form ADV by A••• P••••••• M••••••••• C••••••• L••• (Venture Capital Fund), GAV $101,235,000
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $813M across 4 vehicles
Evidence
45 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2017-04-25Mar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-16Mar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-21Mar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2017-04-25Mar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone415-362-4022Mar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone415-362-4022Mar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionA••• P••••••• is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996.
meta description
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersJackson, WYMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersJackson, WYMar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address115 W. SNOW KING AVE, SUITE 101B, Jackson, WY, 83001Mar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address115 W. SNOW KING AVE, SUITE 101B, Jackson, WY, 83001Mar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
Leading Healthcare Venture Capital Firm | A••• P•••••••
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formLimited PartnershipMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formPartnershipMar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://a•••••••••.com/
0 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://a•••••••••.com/
1 entries read
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported4Mar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported4Mar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$588MMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$813MMar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated sectorsai
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech
sector words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://a•••••••••.com/
0 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://a•••••••••.com/
2 name/title pairs read
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported4Mar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported4Mar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://w••.a•••••••••.comMar 16, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTP://w••.a•••••••••.comMar 21, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleLeading Healthcare Venture Capital Firm | A••• P•••••••
title tag
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)